Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
RAPT Therapeutics, Inc. | Director | Stock Option (right to buy) | 36.5K | $277K | $7.58 | May 22, 2024 | Direct |
Contineum Therapeutics, Inc. | Director | Stock Option (right to buy) | 29.5K | May 24, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CTNM | Contineum Therapeutics, Inc. | May 24, 2024 | 1 | $0 | 4 | May 29, 2024 | Director |
RAPT | RAPT Therapeutics, Inc. | May 22, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
CTNM | Contineum Therapeutics, Inc. | Apr 4, 2024 | 0 | $0 | 3 | Apr 4, 2024 | Director |
RAPT | RAPT Therapeutics, Inc. | May 24, 2023 | 1 | $0 | 4 | May 25, 2023 | Director |
RAPT | RAPT Therapeutics, Inc. | May 25, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
RAPT | RAPT Therapeutics, Inc. | Nov 9, 2021 | 1 | $0 | 4 | Nov 10, 2021 | Director |
RAPT | RAPT Therapeutics, Inc. | Nov 9, 2021 | 0 | $0 | 3 | Nov 10, 2021 | Director |